CME

CME


ASCO/ESMO 2023 Roundtable: Contextualizing the Latest Advances in HER2-Targeted Therapy for Solid Tumors

January 17, 2024

Host: Kathleen Moore, MD, MS

Guest: Susana Banerjee, MBBS, MA, FRCP, PhD

Guest: Shubham Pant, MD, MBBS


HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these